AU2003900481A0 - Synthetic modulators of cell migration and growth - Google Patents

Synthetic modulators of cell migration and growth

Info

Publication number
AU2003900481A0
AU2003900481A0 AU2003900481A AU2003900481A AU2003900481A0 AU 2003900481 A0 AU2003900481 A0 AU 2003900481A0 AU 2003900481 A AU2003900481 A AU 2003900481A AU 2003900481 A AU2003900481 A AU 2003900481A AU 2003900481 A0 AU2003900481 A0 AU 2003900481A0
Authority
AU
Australia
Prior art keywords
protein complexes
cell migration
growth
vitronectin
igf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003900481A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queensland University of Technology QUT
Original Assignee
University of Queensland UQ
Queensland University of Technology QUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, Queensland University of Technology QUT filed Critical University of Queensland UQ
Priority to AU2003900481A priority Critical patent/AU2003900481A0/en
Publication of AU2003900481A0 publication Critical patent/AU2003900481A0/en
Priority to KR1020057014530A priority patent/KR101175687B1/ko
Priority to KR1020127007401A priority patent/KR101179678B1/ko
Priority to AU2004208856A priority patent/AU2004208856B2/en
Priority to US10/544,796 priority patent/US7659367B2/en
Priority to JP2006501345A priority patent/JP4717799B2/ja
Priority to EP10191855.5A priority patent/EP2357195B1/en
Priority to CA2515335A priority patent/CA2515335C/en
Priority to DK04708282.1T priority patent/DK1594895T3/da
Priority to ES04708282T priority patent/ES2372388T3/es
Priority to HK06111795.8A priority patent/HK1091216B/xx
Priority to AT04708282T priority patent/ATE521636T1/de
Priority to EP10191678A priority patent/EP2357194A1/en
Priority to CN2004800093227A priority patent/CN1774448B/zh
Priority to EP04708282A priority patent/EP1594895B1/en
Priority to PCT/AU2004/000117 priority patent/WO2004069871A1/en
Priority to NZ541738A priority patent/NZ541738A/xx
Priority to ZA200506991A priority patent/ZA200506991B/en
Priority to US12/627,647 priority patent/US20100143442A1/en
Priority to US12/793,386 priority patent/US8871709B2/en
Priority to US13/511,776 priority patent/US9090706B2/en
Priority to JP2011005233A priority patent/JP2011120595A/ja
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
AU2003900481A 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth Abandoned AU2003900481A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
AU2003900481A AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth
NZ541738A NZ541738A (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
HK06111795.8A HK1091216B (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
EP10191678A EP2357194A1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
AU2004208856A AU2004208856B2 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
US10/544,796 US7659367B2 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
JP2006501345A JP4717799B2 (ja) 2003-02-05 2004-02-05 成長因子複合体ならびに細胞の移動および増殖の調節
EP10191855.5A EP2357195B1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
CA2515335A CA2515335C (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
DK04708282.1T DK1594895T3 (da) 2003-02-05 2004-02-05 Vækstfaktorkomplekser og modulation af celle-migration og -vækst
ES04708282T ES2372388T3 (es) 2003-02-05 2004-02-05 Complejos de factores de crecimiento y modulación de migración y crecimiento celular.
KR1020057014530A KR101175687B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절
AT04708282T ATE521636T1 (de) 2003-02-05 2004-02-05 Wachstumsfaktorkomplexe und modulation von zellenmigration und -wachstum
KR1020127007401A KR101179678B1 (ko) 2003-02-05 2004-02-05 성장인자 복합체 및 세포 이동 및 성장의 조절
CN2004800093227A CN1774448B (zh) 2003-02-05 2004-02-05 生长因子复合物及细胞迁移和生长的调节
EP04708282A EP1594895B1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
PCT/AU2004/000117 WO2004069871A1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth
ZA200506991A ZA200506991B (en) 2003-02-05 2005-08-31 Growth factor complexes and modulation of cell migration and growth
US12/627,647 US20100143442A1 (en) 2003-02-05 2009-11-30 Growth factor complexes and modulation of cell migration and growth
US12/793,386 US8871709B2 (en) 2003-02-05 2010-06-03 Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
US13/511,776 US9090706B2 (en) 2003-02-05 2010-11-30 Fibronectin: growth factor chimeras
JP2011005233A JP2011120595A (ja) 2003-02-05 2011-01-13 成長因子複合体ならびに細胞の移動および増殖の調節

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003900481A AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth

Publications (1)

Publication Number Publication Date
AU2003900481A0 true AU2003900481A0 (en) 2003-02-20

Family

ID=30005181

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003900481A Abandoned AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth

Country Status (13)

Country Link
US (1) US7659367B2 (https=)
EP (3) EP1594895B1 (https=)
JP (2) JP4717799B2 (https=)
KR (2) KR101175687B1 (https=)
CN (1) CN1774448B (https=)
AT (1) ATE521636T1 (https=)
AU (1) AU2003900481A0 (https=)
CA (1) CA2515335C (https=)
DK (1) DK1594895T3 (https=)
ES (1) ES2372388T3 (https=)
NZ (1) NZ541738A (https=)
WO (1) WO2004069871A1 (https=)
ZA (1) ZA200506991B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
AU2003903896A0 (en) * 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070004037A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for culturing keratinocytes
GB2443370A (en) * 2005-07-29 2008-04-30 Australian Stem Cell Ct Ltd Compositions and methods for growth of pluripotent cells
US20100076489A1 (en) * 2007-03-06 2010-03-25 Joshua Stopek Wound closure material
US8529819B2 (en) * 2007-03-06 2013-09-10 Covidien Lp Wound closure material
US20120058120A1 (en) 2009-03-19 2012-03-08 Tristan Croll Targets for Growth Factor Signalling and Methods of Therapy
CN102725308A (zh) * 2009-11-30 2012-10-10 昆士兰技术大学 纤连蛋白:生长因子嵌合物
US9133266B2 (en) * 2011-05-06 2015-09-15 Wisconsin Alumni Research Foundation Vitronectin-derived cell culture substrate and uses thereof
MX354902B (es) * 2011-11-23 2018-03-23 Bioven 3 Ltd Proteínas recombinantes y sus usos terapéuticos.
HK1220903A1 (zh) * 2013-03-29 2017-05-19 Merrimack Pharmaceuticals, Inc. 软骨结合型融合蛋白
KR101558498B1 (ko) 2013-04-26 2015-10-12 건국대학교 산학협력단 노년황반변성의 진단, 치료 및 예방용 조성물 및 노년황반변성에 대한 진단 방법
JP6169710B2 (ja) * 2013-09-10 2017-07-26 富士フイルム株式会社 多能性幹細胞の培養方法、培養用キット及び多能性幹細胞培養用培地
WO2016105332A1 (en) * 2014-12-22 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170281507A1 (en) * 2014-12-23 2017-10-05 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
WO2016105375A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
MX2017008643A (es) * 2015-03-11 2018-04-26 Allgenesis Biotherapeutics Inc Proteina de fusion que comprende un dominio de union a ligando de factor de crecimiento endotelial vascular (vegf) y factor de crecimiento derivado de plaquetas (pdgf).
WO2019010533A1 (en) * 2017-07-12 2019-01-17 Factor Therapeutics Limited TREATMENT OF OCULAR DISORDERS
WO2023233340A1 (en) * 2022-06-02 2023-12-07 Avant Meats Company Limited Genetically engineered yeast cells, recombinant proteins produced thereof and applications thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US592904A (en) 1897-11-02 Drill
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
CA1341598C (en) 1988-07-15 2009-09-29 Central Sydney Area Health Service Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
JP2866134B2 (ja) * 1990-02-05 1999-03-08 寳酒造株式会社 機能性ポリペプチド
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2829405B2 (ja) * 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5958764A (en) 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
AU6136694A (en) 1993-02-12 1994-08-29 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
DK0862656T3 (da) 1995-11-21 2001-04-09 Univ Yale Unimolekylær segmentamplifikation og -detektering
US5752019A (en) 1995-12-22 1998-05-12 International Business Machines Corporation System and method for confirmationally-flexible molecular identification
US5835382A (en) 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
AU3192299A (en) 1998-03-18 1999-10-11 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
JP2001190280A (ja) * 1999-02-19 2001-07-17 Terumo Corp コラーゲン結合性生理活性ポリペプチド
AU3897200A (en) 1999-03-18 2000-10-04 Hope Heart Institute, The Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
JP2002060400A (ja) * 2000-08-17 2002-02-26 Terumo Corp コラーゲン結合活性および血管新生調節活性を有するハイブリッドポリペプチド
AUPR030900A0 (en) 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex

Also Published As

Publication number Publication date
CN1774448B (zh) 2012-07-18
US20060194292A1 (en) 2006-08-31
CN1774448A (zh) 2006-05-17
CA2515335C (en) 2013-07-30
KR101179678B1 (ko) 2012-09-04
WO2004069871A1 (en) 2004-08-19
EP2357194A1 (en) 2011-08-17
KR20120051747A (ko) 2012-05-22
JP2011120595A (ja) 2011-06-23
KR101175687B1 (ko) 2012-08-22
EP1594895A1 (en) 2005-11-16
EP2357195B1 (en) 2016-06-29
HK1091216A1 (en) 2007-01-12
ES2372388T3 (es) 2012-01-19
KR20050103288A (ko) 2005-10-28
EP1594895B1 (en) 2011-08-24
CA2515335A1 (en) 2004-08-19
ATE521636T1 (de) 2011-09-15
EP1594895A4 (en) 2007-05-09
ZA200506991B (en) 2006-06-28
EP2357195A1 (en) 2011-08-17
NZ541738A (en) 2006-03-31
JP2007523598A (ja) 2007-08-23
JP4717799B2 (ja) 2011-07-06
DK1594895T3 (da) 2011-12-12
US7659367B2 (en) 2010-02-09

Similar Documents

Publication Publication Date Title
AU2003900481A0 (en) Synthetic modulators of cell migration and growth
Bian et al. Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis
Kay et al. TGF-ßs stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts
WO2009064590A3 (en) Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
ATE467425T1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
WO2008096268A3 (en) Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery
BR112012013035A2 (pt) fibronectina: quimeras do fator do crescimento
ATE552849T1 (de) Behandlungsverfahren unter verwendung von ctla-4 antikörpern
NZ603570A (en) Biological materials related to her3
ATE348632T1 (de) Prion protein peptide und deren verwendung
ATE330967T1 (de) An her2 bindende peptidverbindungen
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
MX2010005651A (es) Inhibicion de receptor de proteina de estimulacion de macrofagos (ron) y sus metodos de tratamiento.
WO2008134610A8 (en) Growth factor modified extracellular matrix material and methods for preparation and use thereof
BR112012030821A2 (pt) vitronectina:fator de crescimento quimeras queratinócitos
MX2022007849A (es) Anticuerpos especificos contra la claudina 18.2 tumoral.
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
BR0110190A (pt) Antagonistas de cd40 para uso em tratamento de psorìase e outras condições inflamatórias de pele
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
Lee et al. Matrix-induced nuclear remodeling and mechano-therapeutics
ATE387909T1 (de) Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren
TW200738752A (en) Modulation of MDL-1 activity for treatment of inflammatory disease
ATE349521T1 (de) Mit cd40 und traf interagierende proteine
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
DE60132301D1 (de) Verwendung der extrazellulären Domäne von TRADE Molekülen in Medikamenten zur Behandlung von Neoplasie